Patent directory · USPTO A61K / A61P
Patents matching “vaccine”
821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10555997
Antigens and vaccines directed against human enteroviruses
granted -
US 10548971
MERS-CoV vaccine
granted -
US 10548970
Human rotavirus G9P[6] strain and use as a vaccine
granted -
US 10548964
Antigens and vaccines directed against human enteroviruses
granted -
US 10526414
Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases
granted -
US 10525120
Methods and compositions for live attenuated viruses
granted -
US 10512682
Norovirus vaccine formulations
granted -
US 10513542
Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof
granted -
US 10513543
Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof
granted -
US 10507237
Attenuated African swine fever virus vaccine
granted -
US 10500269
Human rotavirus vaccine strains and diagnostics
granted -
US 10501500
Methods of detection and removal of rhabdoviruses from cell lines
granted -
US 10500271
Compositions and methods for self-adjuvanting vaccines against microbes and tumors
granted -
US 10494440
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke
granted -
US 10478487
Foot-and-mouth disease vaccine
granted -
US 10456461
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
granted -
US 10449231
Compositions and methods for dengue virus chimeric constructs in vaccines
granted -
US 10441642
Immunogenic compositions and vaccines for preventing or treating filarial disease
granted -
US 10443073
Sin Nombre virus full-length M segment-based DNA vaccines
granted -
US 10441645
MSLN targeting DNA vaccine for cancer immunotherapy
granted -
US 10426830
Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions
granted -
US 10420829
Chlamydia vaccine
granted -
US 10420832
Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)
granted -
US 10408834
Mutated parvovirus structural proteins as vaccines
granted